Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
Alcohol (Fayetteville, N.Y.)
|
December 27, 2017
Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis
John B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Hepatology (Baltimore, Md.)
|
August 28, 2020
Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors
Tae-Hwi Schwantes-An, Rebecca Darlay, Philippe Mathurin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 27, 2025
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab
Claudia Campani, Clelia Galvanin, Ju Hyun Shim, et al.
European Journal of Gastroenterology & Hepatology
|
August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.
Journal of Hepatology
|
February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis
Pierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
The Lancet. Gastroenterology & Hepatology
|
February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
Jean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
Journal of Viral Hepatitis
|
November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort
Segolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
Hepatology (Baltimore, Md.)
|
June 28, 2016
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)
Nathalie Ganne-Carrié, Richard Layese, Valérie Bourcier, et al.
Hepatology (Baltimore, Md.)
|
February 14, 2015
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
Jean-Claude Trinchet, Valérie Bourcier, Cendrine Chaffaut, et al.
Journal of Hepatology
|
July 3, 2020
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status
Etienne Audureau, Fabrice Carrat, Richard Layese, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
Alcohol (Fayetteville, N.Y.)
|
December 27, 2017
Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis
John B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Hepatology (Baltimore, Md.)
|
August 28, 2020
Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors
Tae-Hwi Schwantes-An, Rebecca Darlay, Philippe Mathurin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 27, 2025
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab
Claudia Campani, Clelia Galvanin, Ju Hyun Shim, et al.
European Journal of Gastroenterology & Hepatology
|
August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.
Journal of Hepatology
|
February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis
Pierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
The Lancet. Gastroenterology & Hepatology
|
February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
Jean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
Journal of Viral Hepatitis
|
November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort
Segolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
Hepatology (Baltimore, Md.)
|
June 28, 2016
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)
Nathalie Ganne-Carrié, Richard Layese, Valérie Bourcier, et al.
Hepatology (Baltimore, Md.)
|
February 14, 2015
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
Jean-Claude Trinchet, Valérie Bourcier, Cendrine Chaffaut, et al.
Journal of Hepatology
|
July 3, 2020
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status
Etienne Audureau, Fabrice Carrat, Richard Layese, et al.
Page
of 21